M&T Bank
VKTX icon

M&T Bank’s Viking Therapeutics VKTX Stock Holding History

M&T Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Sell
12,446
-2,321
-16% -$75K ﹤0.01% 1214
2026
Q1 		$481K Sell
14,767
-240
-2% -$7.71K ﹤0.01% 1145
2025
Q4 		$529K Buy
15,007
+5,091
+51% +$180K ﹤0.01% 1099
2025
Q3 		$261K Buy
9,916
+313
+3% +$9.34K ﹤0.01% 1270
2025
Q2 		$254K Buy
+9,603
New +$253K ﹤0.01% 1345
2025
Q1 		– Sell
-5,514
Closed -$222K – 1686
2024
Q4 		$222K Sell
5,514
-79
-1% -$4.5K ﹤0.01% 1496
2024
Q3 		$354K Buy
+5,593
New +$328K ﹤0.01% 1294
2022
Q1 		– Sell
-28,648
Closed -$132K – 1651
2021
Q4 		$132K Sell
28,648
-1,873
-6% -$10.5K ﹤0.01% 1493
2021
Q3 		$192K Sell
30,521
-339
-1% -$2.09K ﹤0.01% 1445
2021
Q2 		$185K Hold
30,860
– – ﹤0.01% 1476
2021
Q1 		$195K Sell
30,860
-2,727
-8% -$19.2K ﹤0.01% 1430
2020
Q4 		$190K Buy
33,587
+10
+0% +$61 ﹤0.01% 1530
2020
Q3 		$196K Buy
33,577
+7,287
+28% +$50.2K ﹤0.01% 1431
2020
Q2 		$190K Sell
26,290
-51
-0.2% -$339 ﹤0.01% 1389
2020
Q1 		$123K Buy
26,341
+1,233
+5% +$7.58K ﹤0.01% 1396
2019
Q4 		$201K Buy
25,108
+3,188
+15% +$23.2K ﹤0.01% 1270
2019
Q3 		$151K Buy
21,920
+1,280
+6% +$9.51K ﹤0.01% 1472
2019
Q2 		$171K Sell
20,640
-166
-0.8% -$1.42K ﹤0.01% 1450
2019
Q1 		$207K Buy
+20,806
New +$174K ﹤0.01% 1401

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

M&T Bank's VKTX Position: Q2 2026 in Review

M&T Bank reduced its Viking Therapeutics (VKTX) stake by 16% in Q2 2026, selling an estimated $75K and leaving 12,446 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

M&T Bank first reported a position in VKTX in Q1 2019 and has held it in 19 quarters since. The position peaked at $529K in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • M&T Bank held 12,446 shares of Viking Therapeutics worth $485K as of Q2 2026.
  • M&T Bank sold 2,321 Viking Therapeutics shares in Q2 2026, an estimated $75K.
  • Viking Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1214 holding.
  • M&T Bank first reported a position in Viking Therapeutics in Q1 2019 and has held it in 19 quarters since.
  • M&T Bank's Viking Therapeutics position peaked at $529K in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.